Clinical Trial Update: Evaluation the Efficacy and Safety of Mutiple Lenzumestrocel (Neuronata-R® Inj.) Treatment in Patients with ALS [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of multiple Lenzumestrocel (Neuronata-R) injections in patients with amyotrophic lateral sclerosis, cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Mutiple Lenzumestrocel (Neuronata-R® Inj.) (Lenzumestrocel)

Snippet

Sponsor: Corestemchemon, Inc. | Conditions: Amyotrophic Lateral Sclerosis | Phase 3 | Status: ACTIVE_NOT_RECRUITING